Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ardelyx Inc (NQ: ARDX )

5.231 +0.111 (+2.17%)
Streaming Delayed Price Updated: 12:14 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ardelyx Inc

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
3 Penny Stocks to Buy and Hold for the Next 10 Years
These three penny stocks are the ones to buy and hold through the market conditions and the years to come for returns. 
Via InvestorPlace
Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023
From Ardelyx, Inc.
Via GlobeNewswire
Tesla, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Why Ardelyx Stock Popped Today
Ardelyx finally received the long-awaited FDA approval for its chronic kidney disease drug. 
Via The Motley Fool
Exposures Product Safety
Why Shares of Ardelyx Were Down Wednesday
The company's hopes for approval of a drug to treat chronic kidney disease took a hit. 
Via The Motley Fool
Analyst Expectations for Ardelyx's Future
Via Benzinga
Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023
Conference call scheduled for 8:00 a.m. Eastern Time 
From Ardelyx, Inc.
Via GlobeNewswire
Crude Oil Rises Sharply; Ardelyx Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling more than 1% on Wednesday. The Dow traded down 0.70% to 33,760.26 while the NASDAQ fell 1.45% to 13,338.71. The S&P 500 also... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Shift Technologies, Inc. (NASDAQ: SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Ardelyx Inc. (NASDAQ: ARDX) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
Workhorse (WKHS) Stock Jumps on Drone Business Success
Workhorse stock is getting a boost on Wednesday morning after providing WKHS investors with an update on its drone business. 
Via InvestorPlace
FDA Sends ARDX Stock Soaring After Approving Ardelyx’s Kidney Disease Drug
ARDX stock is rallying after the U.S. Food and Drug Administration (FDA) approved Ardelyx's kidney disease treatment. 
Via InvestorPlace
Exposures Product Safety
After Initial Rejection, FDA Approves Ardelyx's Kidney Disease-Related Drug
The FDA approved Ardelyx Inc's (NASDAQ: ARDX) Xphozah (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on... 
Via Benzinga
Exposures Product Safety
Ardelyx Announces Amendment of Debt Financing Agreement with SLR Capital Partners to Provide $50 Million of Additional Committed Capital
Additional non-dilutive capital extends runway to support the launch of XPHOZAH® (tenapanor) and continued commercial investment into IBSRELA® (tenapanor) in the U.S. 
From Ardelyx, Inc.
Via GlobeNewswire
FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor
From Ardelyx, Inc.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday! 
Via InvestorPlace
Ardelyx to Present Data Updates for XPHOZAH (tenapanor) for Hyperphosphatemia at Kidney Week 2023 November 1-5 in Philadelphia, PA
From Ardelyx, Inc.
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Ardelyx Shares Preliminary Data on Use of IBSRELA® (tenapanor) in Pediatric IBS-C Patients at NASPGHAN 2023
From Ardelyx, Inc.
Via GlobeNewswire
Jim Cramer Likes This Oil Giant Up Almost 28% In A Year — 'It Has Room To Grow'
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Caterpillar Inc. (NYSE: CAT). 
Via Benzinga
Ardelyx Announces Publication of Positive Results from T3MPO-3 Long-Term Open-Label Safety Trial of Tenapanor for IBS-C in the Journal of Neurogastroenterology and Motility
From Ardelyx, Inc.
Via GlobeNewswire
Tenapanor for Hyperphosphatemia Approved in Japan
From Ardelyx, Inc.
Via GlobeNewswire
The 3 Best Penny Stocks to Buy Now: September 2023
When all the focus lies on the largest names of the economy, these best penny stocks to buy offer a great risk/reward ratio. 
Via InvestorPlace
Topics Economy
Exposures Economy
Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
Via Benzinga
The 3 Most Promising Penny Stocks to Own Now
Explore top penny stock picks, not just whims but for powerhouses poised for exponential growth over the long term. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.